FACIT operates as a commercialization venture firm focused on oncology innovation in Ontario. It identifies, accesses, and supports technologies with high potential to address unmet oncology needs by applying venture capital and market-driven investing principles. FACIT's model brings together entrepreneurial scientists, partner institutions, and other stakeholders to commercialize life science innovations. They actively partner with companies, providing capital, experienced executive management, and connections to their industry and investor network to help them grow and scale in Ontario. This "Ontario First" strategy aims to ensure that investments in cancer research have the best opportunity to impact patient care.
Preferred startup development maturity for initial funding deployment.
Oncology, Therapeutics, Diagnostics, Medical Technologies, Imaging, Technology Platforms
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...